The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Rheuminations: How Tiny Ticks Have Fueled Outrage and Acrimony in Some Communities

Rheuminations: How Tiny Ticks Have Fueled Outrage and Acrimony in Some Communities

August 1, 2013 • By Simon M. Helfgott, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Paradoxically, with regards to Lyme disease, some practitioners seem to ignore this rule.7 In their view, the lack of antibody positivity does not preclude the diagnosis of Lyme disease. Furthermore, many of them reject the criteria for diagnosing Lyme disease proposed by the Centers for Disease Control and Prevention or by the Infectious Diseases Society of America (IDSA). In its place, they have coined the term, “chronic Lyme disease” to explain a variety of vague symptoms such as chronic fatigue and cognitive dysfunction that plague many of their patients. One of the chronic Lyme advocacy websites lists 25 possible symptoms of Lyme disease, including testicular or pelvic pain, back pain, sleep disturbances, and mood swings.8

You Might Also Like
  • Letters: Detecting Lyme Disease May Require Thorough Testing
  • Diagnosis, Treatment Updates for Lyme Arthritis
  • Lyme Disease
Explore This Issue
August 2013
Also By This Author
  • How Hospital Design Can Promote Better Patient Outcomes

Although the vast majority of individuals given the diagnosis of chronic Lyme disease do not fulfill the IDSA criteria that are used to diagnose Lyme disease, many self-proclaimed “Lyme literate” physicians liberally prescribe nostrums, including prolonged antimicrobial therapies, in a belief that this approach can eradicate suspected infection and cure the patient of what ails them. Their patients and supporters have created vocal advocacy organizations and established some strong alliances with some politicians.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

One relationship in particular stands out. In November 2006, the Connecticut Attorney General (and currently the senior U.S. Senator from Connecticut) Richard Blumenthal initiated an investigation to determine whether the IDSA violated antitrust laws in the promulgation of its 2006 Lyme disease guidelines. He leveled some serious accusations against the IDSA. “The IDSA’s 2006 Lyme disease guideline panel undercut its credibility by allowing individuals with financial interests—in drug companies, Lyme disease diagnostic tests, patents, and consulting arrangements with insurance companies—to exclude divergent medical evidence and opinion.”9 The IDSA maintained that it had developed the 2006 Lyme disease guidelines on the basis of a proper review of the medical or scientific studies and evidence by a panel of experts in the prevention, diagnosis, and treatment of Lyme disease.

A state attorney general wields a big stick. During his tenure, Blumenthal sued tobacco companies, polluters, Internet pornographers, and other violators of the public trust. Attacking the credibility and professionalism of a medical specialty society made little sense and, in my view, tarnished his image. Perhaps he had some misgivings about the lawsuit because, 18 months after filing it, Blumenthal accepted a proposal from the IDSA to convene an independent panel of medical experts to conduct a one-time review of their guidelines.10 The review panel members, vetted by an ombudsman for potential conflicts of interest, reviewed the entirety of the 2006 guidelines, with particular attention to the recommendations devoted to post–Lyme disease syndromes. After multiple meetings, a public hearing, and extensive review of research and other information, the panel concluded that the recommendations contained in the 2006 guidelines were medically and scientifically justified on the basis of all of the available evidence and that no changes to the guidelines were necessary. Case closed? Not really. Perusing some of the vitriolic commentary on the Internet about the IDSA guidelines will dispel you of that myth!

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 4 5 | Single Page

Filed Under: Rheuminations Tagged With: Borrelia burgdorferi, CDC, Centers for Disease Control and Prevention, diagnose, IDSA, Infectious Diseases Society of America, Lyme Disease, rheumatologist, Tick-Borne Disease, Tick-Borne Illness, ticksIssue: August 2013

You Might Also Like:
  • Letters: Detecting Lyme Disease May Require Thorough Testing
  • Diagnosis, Treatment Updates for Lyme Arthritis
  • Lyme Disease
  • Lyme Arthritis Treatment Protocols Critical as Lyme Disease Spreads

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.